• NIA Innovations & COVID-19
  • Newsletter Sign-Up
  • FAQs
  • Case Studies
  • Contact Us
NIANIANIANIA
  • About
    • What the NIA offers
    • Selection Process
    • Core Team
    • Mentors
    • Partners
    • Collaborate
    • Apply
  • Fellows and Innovations
    • Overview
    • Fellows
    • Innovations
    • Alumni
  • Latest
    • Events
    • News & blogs

NHS in Thames Valley to tackle sleeping pills epidemic with digital medicine

    Home News NHS in Thames Valley to tackle sleeping pills epidemic with digital medicine
    NextPrevious

    NHS in Thames Valley to tackle sleeping pills epidemic with digital medicine

    By admin | News | Comments are Closed | 16 March, 2018 | 0

    People across Berkshire, Buckinghamshire, and Oxfordshire will be eligible for free access to Sleepio following an award of almost £1million that could spur its adoption across the NHS.

    The backing from agency Innovate UK will fund research into the rollout of Sleepio, the online sleep improvement programme created by digital medicine company Big Health, in partnership with Oxford Academic Health Science Network (AHSN). Sleepio is one of the 37 innovations currently being supported by the NHS Innovation Accelerator (NIA).

    From October 2018, anyone in the targeted areas will be able to access Sleepio without needing a prescription or referral from their GP, saving valuable time for both patients and doctors. This is the first NHS rollout of direct-access digital medicine – fully automated, evidence-based behavioural medicine self-help programmes, easily accessible via app or web.

    The 28-month project will evidence the best ways of enabling people to access digital medicine, including partnering with stakeholders such as GPs, pharmacies, libraries and local employers. It will develop a blueprint for wider uptake of digital medicine across the NHS in England in a bid to improve sleep health whilst reducing the current over-reliance on medication, which is used to treat the estimated 20% of working adults that suffer from chronic sleeplessness.

    Last year, over 12 million prescriptions for insomnia were written, at a cost to the NHS of £72million – one prescription for every GP, every day of the year. In clinical trials, Sleepio has been shown to help over three-quarters of insomnia sufferers achieve normal sleep.

    Clinical guidelines recommend a psychological approach called cognitive behavioural therapy (CBT) for insomnia. However, treatment is currently dominated by medication, which can have unpleasant or harmful side effects.

    Sleepio is a fully automated and scalable web and mobile programme, based on CBT, shown in clinical trials to help individuals make the necessary changes to transform their sleep, mental health and productivity. Sleepio is clinically proven to help 76% of those with insomnia make the changes necessary to achieve healthy sleep levels. In psychological therapy settings, 68% of those with anxiety and depression move to recovery.

    Professor Colin Espie, Co-Founder and Chief Medical Officer at Big Health said:

    “This project is critical to demonstrate how digital medicine can offer better quality care to people experiencing insomnia, reduce reliance on medication and enable people to engage in effective self-care.”

    Oxford AHSN will work in partnership with Big Health to explore the best ways for people experiencing insomnia to access Sleepio. Working with GPs, and primary and mental health NHS staff, local employers, and third sector organisations, Oxford AHSN will explore how the NHS can expand provision of digital medicines like Sleepio.

    Dr Michael Mulholland, Buckinghamshire GP and Clinical Lead for this project said:

    “In my role as a GP I see the impact of insomnia on people’s’ lives every day. Sleepio offers a real opportunity to transform lives for the better and to reduce reliance on sleeping tablets. This collaboration will explore the potential of digital innovations to improve people’s lives.”

    Sleepio is one of the first digital health applications ever to be reviewed by NICE, and has been supported by the NHS Innovation Accelerator since 2015. Sleepio has been tested in six clinical trials, including the largest ever trial of a psychological intervention, significantly improving both sleep and mental health outcomes (Freeman et al. 2017).

    More information about Sleepio and NIA Fellow Sophie Bostock is available here.

    No tags.

    Related Posts

    • The new palliative care gold standard

      By admin | Comments are Closed

      By: Julia Riley The EIU’s recent Quality of Death report praised palliative care in the UK as the best in the world, citing the quality and availability of services provided by the NHS and hospice movement as “second toRead more

    • Nervecentre Software win prestigious Building Better Healthcare Award

      By admin | Comments are Closed

      Nervecentre Software in partnership with Nottingham University Hospitals NHS Trust have won the prestigious award for ‘Best Communications and IT product’ at the Building Better Healthcare Awards, held on 4th November 2015, The award isRead more

    • Southend University Hospital NHS Foundation Trust live with Nervecentre electronic observations

      By admin | Comments are Closed

      Southend University Hospital NHS Foundation Trust has now deployed Nervecentre Electronic Observations software using mobiles devices across the hospitals to improve patient safety and communications. Funded through the Nursing Technology Fund, Electronic Observations are now liveRead more

    • Nervecentre in Australia… Success at the ISRRS Symposium in Melbourne


      By admin | Comments are Closed

      Written by Jim Trueman Attendees of the symposium held by the International Society for Rapid Response Systems and Medical Emergency Teams are all clinicians that intuitively recognise the problems that Nervecentre was designed to solve. Read more

    • i-THRIVE: Manchester and Salford’s Integrated Access and Care Pathways 


      By admin | Comments are Closed

      What was the problem you were trying to solve? Central Manchester University Hospitals NHS Foundation Trust (CMFT) provide child and adolescent mental health services (CAMHS) for Manchester and Salford. The move towards Integrated Access andRead more

    • Coordinate My Care Integrates Care Plans into Emis Web

      By admin | Comments are Closed

      Urgent care plans for thousands of London’s most vulnerable patients care are now just a click away for almost 1,000 of their GPs. Plan sharing scheme Coordinate my Care will now be available to 962Read more

    • OWise breast cancer app proven to be effective tool in cancer treatment process

      By admin | Comments are Closed

      Innovative patient support app shown in peer-reviewed medical journal to improve patient-doctor interactions and is recommended by 90% of patients and clinicians OWise breast cancer, the first mobile app to offer patients personalised medical supportRead more

    • OBH featured in TeleMedicine Magazine

      By admin | Comments are Closed

      Telemedicine Magazine included an article on Outcome Based Healthcare (OBH) in their series focusing on the growing trend of doctors getting involved with healthcare start-ups. Rupert, OBH CEO, explained that during his time as aRead more

    NextPrevious
    Contact Us
    nia@uclpartners.com
    @NHSAccelerator
    Newsletter Sign-Up
    Terms and Conditions | Privacy and Cookies
    NHS Innovation Accerlator
    Copyright 2017 NHS Innovation Accelerator
    • Menu
      • Latest
      • Case Studies
      • News and Events
      • Press and Media
      • FAQs (OLD)
      • Contact Us
    • Apply
    • Fellows and Innovations
      • Fellows
      • Innovations
    • Collaborate
    • Accelerator
      • Partners
      • What the NIA offers
      • Selection Process
      • Mentors
    NIA